Use of asthma medication during pregnancy and risk of specific congenital anomalies: A European case-malformed control study  Ester Garne, MD, Anne Vinkel Hansen, MSc, Joan Morris, PhD, Louise Zaupper, MD, Marie-Claude Addor, MD, Ingeborg Barisic, PhD, Miriam Gatt, MD, MSc, Nathalie Lelong, MSc, Kari Klungsøyr, MD, PhD, Mary O'Mahony, MFPHMI, Vera Nelen, MD, Amanda J. Neville, BSc, Anna Pierini, BSc, David Tucker, MPH, Hermien de Walle, PhD, Awi Wiesel, MD, MSc, Maria Loane, PhD, Helen Dolk, PhD  Journal of Allergy and Clinical Immunology  Volume 136, Issue 6, Pages 1496-1502.e7 (December 2015) DOI: 10.1016/j.jaci.2015.05.043 Copyright © 2015 The Authors Terms and Conditions

Fig 1 Flowchart describing the literature review. Journal of Allergy and Clinical Immunology 2015 136, 1496-1502.e7DOI: (10.1016/j.jaci.2015.05.043) Copyright © 2015 The Authors Terms and Conditions

Fig 2 Flowchart describing inclusions and exclusions for the signal testing analysis. For exploratory analysis, registrations exposed to unspecified antiasthma medications were included. Journal of Allergy and Clinical Immunology 2015 136, 1496-1502.e7DOI: (10.1016/j.jaci.2015.05.043) Copyright © 2015 The Authors Terms and Conditions